Le Lézard
Classified in: Health, Science and technology
Subjects: CCA, FVT

Zimmer Biomet Announces Webcast and Conference Call of First Quarter 2021 Financial Results


WARSAW, Ind., April 6, 2021 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced its first quarter earnings conference call will be webcast on Tuesday, May 4, 2021 at 8:30 a.m. ET.  A news release detailing the quarterly results will be made available that day at 6:30 a.m. ET.

The live audio webcast can be accessed via Zimmer Biomet's Investor Relations website at https://investor.zimmerbiomet.com.  It will be archived for replay following the conference call.

Individuals in the U.S. and Canada who wish to dial into the conference call may do so by dialing (888) 312-9837 and entering conference ID 7278985.  For a complete listing of international toll-free and local numbers, please visit https://investor.zimmerbiomet.com.  A digital recording will be available after the completion of the conference call, from May 4, 2021 to July 6, 2021.  To access the recording, U.S. callers should dial (888) 203-1112 and international callers should dial +1 (719) 457-0820, and enter the Access Code ID 7278985.

About the Company
Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer Biomet is a global leader in musculoskeletal healthcare.  We design, manufacture and market orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office based technologies; spine, craniomaxillofacial and thoracic products; dental implants; and related surgical products.

We collaborate with healthcare professionals around the globe to advance the pace of innovation.  Our products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues.  Together with healthcare professionals, we help millions of people live better lives.

We have operations in more than 25 countries around the world and sell products in more than 100 countries.  For more information, visit www.zimmerbiomet.com, or follow Zimmer Biomet on Twitter at www.twitter.com/zimmerbiomet.

ZBH-Fin

Media


Investors

Meredith Weissman


Keri Mattox

703-346-3127


215-275-2431

[email protected]


[email protected]






Ezgi Yagci



617-549-2443



[email protected]

 

SOURCE Zimmer Biomet Holdings, Inc.


These press releases may also interest you

at 14:06
CarSaver Crowned Gold Stevie® Award Winner for Most Innovative Tech Company of the Year 2024
In a significant acknowledgment of its pioneering advancements in the automotive industry, CarSaver has been honored with the prestigious Gold Stevie® Award for Most Innovative Tech Company of the Year 2024. This accolade, awarded by the American...

at 14:05
Synedgen Completes IND-Enabling Studies for Two Parallel Programs for Lead Asset MIIST305
Synedgen, Inc., a biotechnology company targeting human glycobiology to treat gastrointestinal diseases, today announced it has completed IND-enabling studies for its lead candidate, MIIST305. MIIST305 is being developed for two parallel programs, an...

at 14:00
Introducing TacView Plus Portable Mission Display: The Next Evolution in Mission-Critical Technology
CMC Electronics, a leader in innovative mission-critical solutions, is proud to announce the launch of TacView Plus, the latest advancement in our renowned TacView product line. Building upon the success of TacView, TacView Plus represents a...

at 13:56
First Student Launches Six New Electric School Buses in Pennsylvania from EPA Round One Funding
Today, First Student, the leading school transportation provider in North America, and proven industry leader in electrification, hosted a ribbon-cutting ceremony at Steelton-Highspire School District celebrating the deployment of the first electric...

at 13:55
Unveiling NyquistIQ: Your AI-Powered Research Assistant in Extracting Insights from the Data Deluge
Data is everywhere, but insight is rare. Insights are hidden deep in the data and require tons of work and time to dig out. Knowledge professionals in clinical trials, medical, strategy, and regulatory affairs are struggling with the rapid growth of...

at 13:50
Wild Turkey® Bourbon Announces Third Annual 101 Bold Nights Concert Series Featuring Warren Zeiders
Wild Turkey® Bourbon today announced Warren Zeiders as the headliner for its third annual 101 Bold Nights concert series, an initiative that aims to elevate bold voices in the music industry by spotlighting artists who share the brand's commitment to...

More news about Science and technology...


News published on and distributed by: